Saunders KC - Search Results

1

Clinical analysis of sampatrilat, a combined renal endopeptidase and angiotensin-converting enzyme inhibitor I: assay in plasma of human volunteers by atmospheric-pressure ionisation mass-spectrometry following derivatisation with BF3-methanol.

Venn RF, Kaye B, Macrae PV, Saunders KC. Venn RF, et al. Among authors: saunders kc. J Pharm Biomed Anal. 1998 Jan;16(5):875-81. doi: 10.1016/s0731-7085(97)00126-x. J Pharm Biomed Anal. 1998. PMID: 9535199

2

Clinical analysis of sampatrilat, a combined renal endopeptidase and angiotensin-converting enzyme inhibitor II: assay in the plasma and urine of human volunteers by dissociation enhanced lanthanide fluorescence immunoassay (DELFIA).

Venn RF, Barnard G, Kaye B, Macrae PV, Saunders KC. Venn RF, et al. Among authors: saunders kc. J Pharm Biomed Anal. 1998 Jan;16(5):883-92. doi: 10.1016/s0731-7085(97)00127-1. J Pharm Biomed Anal. 1998. PMID: 9535200

3

Evolution of an open-access quantitative bioanalytical mass spectrometry service in a drug discovery environment.

Wright P, Chassaing C, Cussans N, Gibson D, Green C, Gleave M, Jones R, Macrae P, Saunders K. Wright P, et al. Biomed Chromatogr. 2006 Jun-Jul;20(6-7):585-96. doi: 10.1002/bmc.668. Biomed Chromatogr. 2006. PMID: 16779781

4

An automated, high-throughput, 384 well Cytochrome P450 cocktail IC50 assay using a rapid resolution LC-MS/MS end-point.

Youdim KA, Lyons R, Payne L, Jones BC, Saunders K. Youdim KA, et al. J Pharm Biomed Anal. 2008 Sep 10;48(1):92-9. doi: 10.1016/j.jpba.2008.05.011. Epub 2008 May 17. J Pharm Biomed Anal. 2008. PMID: 18584988

5

A review of LC-MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s.

Youdim KA, Saunders KC. Youdim KA, et al. Among authors: saunders kc. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 May 15;878(17-18):1326-36. doi: 10.1016/j.jchromb.2010.02.013. Epub 2010 Feb 17. J Chromatogr B Analyt Technol Biomed Life Sci. 2010. PMID: 20207203 Review.

6

Separation and sample pre-treatment in bioanalysis using monolithic phases: A review.

Saunders KC, Ghanem A, Boon Hon W, Hilder EF, Haddad PR. Saunders KC, et al. Anal Chim Acta. 2009 Oct 12;652(1-2):22-31. doi: 10.1016/j.aca.2009.05.043. Epub 2009 Jun 7. Anal Chim Acta. 2009. PMID: 19786168 Review.

7

Automation and robotics in ADME screening.

Saunders KC. Saunders KC. Drug Discov Today Technol. 2004 Dec;1(4):373-80. doi: 10.1016/j.ddtec.2004.11.009. Drug Discov Today Technol. 2004. PMID: 24981617

8

(-)-N-3-Benzylphenobarbital Is Superior to Omeprazole and (+)-N-3-Benzylnirvanol as a CYP2C19 Inhibitor in Suspended Human Hepatocytes.

Cuypers ML, Chanteux H, Gillent E, Bonnaillie P, Saunders K, Beckers C, Delatour C, Dell'Aiera S, Ungell AL, Nicolaï J. Cuypers ML, et al. Drug Metab Dispos. 2020 Nov;48(11):1121-1128. doi: 10.1124/dmd.120.000089. Epub 2020 Aug 24. Drug Metab Dispos. 2020. PMID: 32839278

9

Kappa agonist CovX-Bodies.

Roberts LR, Brady K, Brown A, Davey D, Feng L, Huang H, Liu D, Malet L, McMurray G, Phelan A, Saunders K, Bhat A. Roberts LR, et al. Bioorg Med Chem Lett. 2012 Jun 15;22(12):4173-8. doi: 10.1016/j.bmcl.2012.04.040. Epub 2012 Apr 25. Bioorg Med Chem Lett. 2012. PMID: 22583618

10

Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio.

Nicolaï J, Chapy H, Gillent E, Saunders K, Ungell AL, Nicolas JM, Chanteux H. Nicolaï J, et al. Pharm Res. 2020 Aug 27;37(9):175. doi: 10.1007/s11095-020-02867-z. Pharm Res. 2020. PMID: 32856111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page